V. Zikán

发表

Association of macrophage inhibitory cytokine-1 with nutritional status, body composition and bone mineral density in patients with anorexia nervosa: the influence of partial realimentation

M. Haluzík, H. Papezová, P. Kavalkova, 2010, Nutrition & metabolism.

Prevalence and Risk Factors of Osteoporosis in Postmenopausal Women with Type 2 Diabetes Mellitus.

I. Raška, J. Škrha, M. Rasková, 2017, Central European journal of public health.

Calcitonin load test to assess the efficacy of salmon calcitonin.

J. Stepan, V. Zikán, 2003, Clinica chimica acta; international journal of clinical chemistry.

Plasma type 1 collagen cross-linked C-telopeptide: a sensitive marker of acute effects of salmon calcitonin on bone resorption.

J. Stepan, V. Zikán, 2002, Clinica chimica acta; international journal of clinical chemistry.

High Prevalence of Hypovitaminosis D in Postmenopausal Women with Type 2 Diabetes Mellitus.

I. Raška, J. Škrha, M. Rasková, 2016, Prague medical report.

Effects of morning vs. evening teriparatide injection on bone mineral density and bone turnover markers in postmenopausal osteoporosis

I. Raška, A. Kuběna, J. Stepan, 2012, Osteoporosis International.

Markers of bone remodeling predict rate of bone loss in multiple sclerosis patients treated with low dose glucocorticoids.

E. Havrdová, D. Horáková, M. Týblová, 2004, Clinica chimica acta; international journal of clinical chemistry.

Inflammatory markers in primary aldosteronism.

T. Zelinka, M. Haluzík, J. Rosa, 2016, Physiological research.

Marker of Bone Resorption in Acute Response to Exogenous or Endogenous Parathyroid Hormone

J. Stepan, V. Zikán, 2008, Biomarker insights.

Preadipocyte factor-1 concentrations in patients with anorexia nervosa: the influence of partial realimentation.

M. Haluzík, H. Papezová, Z. Lacinová, 2012, Physiological research.

The effect of timing of teriparatide treatment on the circadian rhythm of bone turnover in postmenopausal osteoporosis.

I. Raška, A. Kuběna, J. Stepan, 2011, European journal of endocrinology.

Acute Effects in Healthy Women of Oral Calcium on the Calcium-Parathyroid Axis and Bone Resorption as Assessed by Serum b-CrossLaps

J. Stepan, V. Zikán, T. Haas, 2001, Calcified Tissue International.

Diminished Acute Response of Osteoclasts to Calcium Load in Thyroidectomized Patients

J. Stepan, V. Zikán, 2004, Calcified Tissue International.

Proximal Femur Bone Density of the Great Moravian Population from Mikulčice Evaluated by Dual-Energy X-ray Absorptiometry

P. Velemínský, J. Likovský, V. Zikán, 2009 .

Osteoporosis in men: underappreciated and undertreated.

V. Zikán, 2021, Vnitrni lekarstvi.

Osteoporosis and fractures in multiple sclerosis : pathogenesis , risk factors , treatment options , and prevention

M. Týblová, V. Zikán, Ivana Kvasničková, 2019 .

Bone mineral density and body composition in men with multiple sclerosis chronically treated with low-dose glucocorticoids.

E. Havrdová, I. Raška, A. Kuběna, 2012, Physiological research.

Bone Health in Patients with Multiple Sclerosis

Vit Zikan, V. Zikán, 2011, Journal of osteoporosis.

Body composition is associated with bone and glucose metabolism in postmenopausal women with type 2 diabetes mellitus.

I. Raška, J. Škrha, M. Rasková, 2017, Physiological research.

Effects of teriparatide and risedronate on new fractures in post-menopausal women with severe osteoporosis (VERO): a multicentre, double-blind, double-dummy, randomised controlled trial

P. Geusens, E. Lespessailles, P. López-Romero, 2017, The Lancet.

Plasma concentrations of adipocyte fatty acid binding protein in patients with Cushing's syndrome.

M. Matoulek, M. Haluzík, V. Hána, 2010, Physiological research.

Diabetes, Cardiovascular Disorders and 2,3,7,8‐Tetrachlorodibenzo‐p‐Dioxin Body Burden in Czech Patients 50 Years After the Intoxication

J. Škrha, D. Pelclova, T. Navrátil, 2018, Basic & clinical pharmacology & toxicology.

Increased oxidative/nitrosative stress markers measured non- invasively in patients with high 2,3,7,8-tetrachloro-dibenzo-p-dioxin plasma level.

D. Pelclova, T. Navrátil, K. Kupka, 2011, Neuro endocrinology letters.

Plasma concentrations of fibroblast growth factors 21 and 19 in patients with Cushing's syndrome.

M. Matoulek, M. Haluzík, V. Hána, 2010, Physiological research.

Impaired ambulation and steroid therapy impact negatively on bone health in multiple sclerosis

E. Havrdová, T. Kalincik, M. Týblová, 2015, European journal of neurology.

Osteoporosis in adults in clinical practice (1): diagnosis and differential diagnosis.

V. Zikán, 2023, Vnitrni lekarstvi.

Tumor induced osteomalacia - A long way toward correct diagnosis and management

M. Michal, D. Netuka, L. Filipová, 2022, Bone reports.

Marked reduction of bone turnover by alendronate attenuates the acute response of bone resorption marker to endogenous parathyroid hormone.

J. Stepan, V. Zikán, 2009, Bone.

Open Access Research

M. Haluzík, P. Kavalkova, I. Dostálová, 2022 .

Effects of teriparatide and risedronate on new fractures in post-menopausal women with severe osteoporosis (VERO): a multicentre, double-blind, double-dummy, randomised controlled trial

P. Geusens, E. Lespessailles, P. López-Romero, 2017, The Lancet.

Acute effects of calcium carbonate and milk on the calcium-parathyroid axis and bone resorption in healthy women.

B. Dawson-Hughes, R. Heaney, P. Roubal, 2001 .

Pharmacological treatment of osteoporosis and prevention of fractures: recommendations for clinical practice

V. Zikán, 2024, Vnitřní lékařství.

Bone mineral density and body composition in men with multiple sclerosis chronically treated with low-dose glucocorticoids.

E. Havrdová, I. Raška, M. Týblová, 2012, Physiological research.